Suppr超能文献

金黄色葡萄球菌所致中心静脉导管定植并不总是需要进行抗菌治疗的指征。

Central venous catheter colonization with Staphylococcus aureus is not always an indication for antimicrobial therapy.

机构信息

Department of Clinical Microbiology and Infectious Diseases, Hospital General Universitario Gregorio Marañón, Madrid, Spain.

出版信息

Clin Microbiol Infect. 2012 Sep;18(9):877-82. doi: 10.1111/j.1469-0691.2011.03683.x. Epub 2011 Oct 17.

Abstract

Whether patients whose catheter tip grows Staphylococcus aureus but who have no concomitant bacteraemia should receive antimicrobials remains an unresolved issue. However, a proportion of patients with catheter tips colonized by S. aureus have no blood cultures taken because of low suspicion of sepsis and the meaning of this microbiological finding is unknown. We have analysed all catheter tips growing S. aureus during a 6-year period and have selected patients without blood cultures taken 7 days before or after central vascular catheter removal. Patient's evolution was classified into good and poor outcome. Poor outcome was defined as S. aureus infection within 3 months after catheter withdrawal or death in the same period with no obvious cause. Patients with good and poor outcomes were compared to assess whether antimicrobial therapy influenced evolution. Sixty-seven patients fulfilled our inclusion criteria and five (7.4%) had a poor outcome. The administration of early anti-staphylococcal therapy had no impact on the outcome of this population (p 0.99). The only factor independently associated with a poor outcome was the presence of clinical signs of sepsis when the catheter was removed (OR 20.8; 95% CI 2.0-206.1; p 0.009). Our data suggest that patients with central vascular catheter tips colonized with S. aureus should be closely monitored for signs and symptoms of ongoing infection, but if these are not present then antimicrobial therapy does not seem justified.

摘要

对于那些导管尖端生长金黄色葡萄球菌但没有合并菌血症的患者是否应接受抗生素治疗,目前仍存在争议。然而,由于怀疑败血症的可能性低,并且这种微生物学发现的意义尚不清楚,一部分导管尖端被金黄色葡萄球菌定植的患者并未进行血培养。我们分析了在 6 年期间生长金黄色葡萄球菌的所有导管尖端,并选择了在中央血管导管拔出前 7 天或后 7 天未进行血培养的患者。将患者的病情分为良好和不良结局。不良结局定义为导管拔出后 3 个月内发生金黄色葡萄球菌感染或同期无明显原因死亡。比较了具有良好和不良结局的患者,以评估抗生素治疗是否影响病情。符合纳入标准的患者有 67 例,其中 5 例(7.4%)预后不良。早期抗葡萄球菌治疗对该人群的结局没有影响(p 0.99)。唯一与不良结局独立相关的因素是导管拔出时存在败血症的临床症状(OR 20.8;95%CI 2.0-206.1;p 0.009)。我们的数据表明,应密切监测中央血管导管尖端定植金黄色葡萄球菌的患者是否有持续感染的迹象和症状,但如果没有这些迹象和症状,抗生素治疗似乎没有必要。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验